Search NXGL
NEXGEL, INC.
Nasdaq, Nasdaq · CIK 1468929
Last close0.17
Daily change-0.01 (-2.79%)
10 Years gain-95.06%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
NXGL · STANDARD
SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231
Fundamental
38.2Momentum
20.7Acceleration
12.4Confidence
63.0Annual Revenue4
Quarterly Revenue12
Annual CFO8
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth23.8 / 25
Quality12.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet0.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 1.5135 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Warnings
Operating margin compression · MEDIUMOperating margin compressed by 5.8619 percentage points.
Heavy share dilution · HIGHDiluted share count increased 17.8927%.
ROIC declining · MEDIUMROIC declined by 42.7052 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.
Key Metrics
Revenue Growth TTM18.83%OK
Revenue CAGR 3Y77.33%OK
Gross Margin38.43%OK
Operating Margin-39.69%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-96.21%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y17.89%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $11.42M | $4.51M | -$3.35M | -$1.31M | -$1.38M | 39.48% | -29.35% | -12.07% | -46.11% | 7.85M |
| 2025 FY Dec 31, 2024 | $8.69M | $2.75M | -$3.55M | -$3.87M | -$4.31M | 31.63% | -40.91% | -49.61% | -47.87% | 6.51M |
| 2024 FY Dec 31, 2023 | $4.09M | $374,000.00 | -$3.48M | -$3.24M | -$3.93M | 9.15% | -85.03% | -96.16% | -71.33% | 5.67M |
| 2023 FY Dec 31, 2022 | $2.05M | $256,000.00 | -$3.35M | -$2.99M | -$3.09M | 12.5% | -163.48% | -150.78% | -461.19% | 5.57M |
| 2022 FY Dec 31, 2021 | n/a | $8,000.00 | -$2.57M | -$2.75M | -$3.02M | n/a | n/a | n/a | n/a | n/a |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $12.15M | sum latest 4 fiscal quarters Revenue | OK | 0001493152-26-038555, 0001493152-25-021738 |
| Revenue Growth TTM | 18.83% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001493152-26-038555, 0001493152-25-021738 |
| Revenue CAGR 3Y | 77.33% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-014377 |
| Revenue CAGR 5Y | n/a | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | INSUFFICIENT_HISTORY | 0001493152-26-014377 |
| Gross Profit CAGR 3Y | 160.18% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001493152-26-014377 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001493152-26-038555, 0001493152-25-021738 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 38.43% | Gross Profit / Revenue | OK | 0001493152-26-038555, 0001493152-25-021738 |
| Operating Margin | -39.69% | Operating Income / Revenue | OK | 0001493152-26-038555, 0001493152-25-021738 |
| ROIC | -96.21% | NOPAT / Average Invested Capital | OK | 0001493152-26-038555, 0001493152-25-021738 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001493152-26-038555 |
| Current Ratio | 0.43x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $1.35 | Revenue / Diluted Shares | OK | 0001493152-26-038555, 0001493152-25-021738 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |